A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
Clinical trial NCT04522323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04522323
- Sponsor
- MedImmune LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2025-09-26
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.